dukeeye.org

DUKE EYE CENTER

DUKE UNIVERSITY MEDICAL CENTER

enlarge textreduce text
World-Class Eye Care and ResearchAccessibility Statement

Edward G. Buckley, MD

Edward G. Buckley, MD

Professor of Ophthalmology and Pediatrics

Chief, Pediatric Ophthalmology and Strabismus Service

Chief, Neuro-Ophthalmology Service

Medical school

Duke University School of Medicine

Residency

Duke Eye Center

Fellowship

Bascom Palmer Eye Institute

Background

Edward Buckley, MD, specializes in pediatric eye disorders and adult/childhood strabismus. He has special expertise in the treatment of complicated ocular motility disorders secondary to cranial nerve palsies, thyroid ophthalmopathy, and trauma. He has been a national leader in the treatment of congenital cataracts, retinoblastoma and retinopathy of prematurity. He is one of the few individuals in the country trained in both pediatric and neuro-ophthalmology. This additional skill enables him to deal with ocular problems secondary to neurological disease in both children and adults. Buckley was one of the original investigators using Botulinum toxin to treat eye disorders and has more than 20 years of experience in the treatment of blepharospasm, hemifacial spasm, and strabismus with Botulinum toxin. He has written more than 90 scientific articles, 30 book chapters, several books, and has lectured all over the world. He has been included in the Best Doctors in America since its inception in 1992.

Phone

919.684.3957

Fax

919.684.6096 

Research Interests

  • Congenital cataracts: Investigation is underway to determine the efficacy and safety of intraocular lens implants in children. This includes both primary and secondary implants.
  • Management of complicated eye muscle disorders: New surgical techniques are being evaluated in the treatment of paralytic and restrictive strabismus. Investigations into the possibility of developing a material which could serve as an "artificial muscle" are in progress. 
  • Retinopathy of prematurity: Efforts are currently underway to study the efficacy, timing, and long-term safety of treatment. 
  • Retinoblastoma: Investigating new chemotherapy and radiation treaments to preserve vision. 
  • Botulinum toxin: Work is underway to ascertain the usefulness of botulinum toxin in the treatment of headaches.
  • Evaluating the effectiveness of optic nerve sheath decompression for optic nerve swelling.

Representative Publications

  1. Buckley EG, Freedman SF, Enyedi LB, Toth CA. Surgical treatment of incyclotorsion after macular translocation. AOJ 2001:51:16-23.
  2. Buckley EG. Transscleral fixated posterior chamber intraocular lenses in children. JAAPOS 1999:3:289-94.
  3. Portellos M, Buckley EG. Cataract surgery and intraocular lens implantation in retinoblastoma patients. Arch Ophthalmol 1998:116:449-452.
  4. Buckley EG, Klombers L, Seaber JH, Gordy A, Minzter R. Management of the posterior capsule in pediatric IOL's. Am J Ophthalmol 1993:115:722-728.
  5. Buckley EG, Heath H. Visual acuity post treatment of large macular retinoblastoma. J Ped Ophthalmol and Strabismus 1992:29:103-106.
  6. Buckley EG, Townshend LT. A simple transposition procedure for complicated strabismus. Am J Ophthalmol 1991:111:302-306.
  7. Buckley EG, Meekins B. Fadenoperation in incomitant vertical strabismus. Am J Ophthalmol 1988:105:304.
  8. Buckley EG, Seaber JH. Dyskinetic strabismus as a sign of cerebral palsy. Am J Ophthalmol 1981:91:652.